Global Microneedle Flu Vaccine Market Research Report 2021

Global Microneedle Flu Vaccine Market Research Report 2021

Table of Contents
1 Microneedle Flu Vaccine Market Overview
1.1 Product Overview and Scope of Microneedle Flu Vaccine
1.2 Microneedle Flu Vaccine Segment by Type
1.2.1 Global Microneedle Flu Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Solid Microneedle
1.2.3 Hollow Microneedle
1.2.4 Coated Microneedle
1.2.5 Dissolving Microneedle
1.3 Microneedle Flu Vaccine Segment by Application
1.3.1 Global Microneedle Flu Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Influenza A
1.3.3 Influenza B
1.4 Global Microneedle Flu Vaccine Market Size Estimates and Forecasts
1.4.1 Global Microneedle Flu Vaccine Revenue 2016-2027
1.4.2 Global Microneedle Flu Vaccine Sales 2016-2027
1.4.3 Microneedle Flu Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Microneedle Flu Vaccine Market Competition by Manufacturers
2.1 Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Microneedle Flu Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Microneedle Flu Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Microneedle Flu Vaccine Market Competitive Situation and Trends
2.5.1 Microneedle Flu Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Microneedle Flu Vaccine Players Market Share by Revenue
2.5.3 Global Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microneedle Flu Vaccine Retrospective Market Scenario by Region
3.1 Global Microneedle Flu Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Microneedle Flu Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Microneedle Flu Vaccine Market Facts & Figures by Country
3.3.1 North America Microneedle Flu Vaccine Sales by Country
3.3.2 North America Microneedle Flu Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Microneedle Flu Vaccine Market Facts & Figures by Country
3.4.1 Europe Microneedle Flu Vaccine Sales by Country
3.4.2 Europe Microneedle Flu Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Microneedle Flu Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Microneedle Flu Vaccine Sales by Region
3.5.2 Asia Pacific Microneedle Flu Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Microneedle Flu Vaccine Market Facts & Figures by Country
3.6.1 Latin America Microneedle Flu Vaccine Sales by Country
3.6.2 Latin America Microneedle Flu Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Microneedle Flu Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Microneedle Flu Vaccine Sales by Country
3.7.2 Middle East and Africa Microneedle Flu Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Microneedle Flu Vaccine Historic Market Analysis by Type
4.1 Global Microneedle Flu Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Microneedle Flu Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Microneedle Flu Vaccine Price by Type (2016-2021)
5 Global Microneedle Flu Vaccine Historic Market Analysis by Application
5.1 Global Microneedle Flu Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Microneedle Flu Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Microneedle Flu Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi Microneedle Flu Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GC Pharma
6.2.1 GC Pharma Corporation Information
6.2.2 GC Pharma Description and Business Overview
6.2.3 GC Pharma Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GC Pharma Microneedle Flu Vaccine Product Portfolio
6.2.5 GC Pharma Recent Developments/Updates
6.3 Debiotech
6.3.1 Debiotech Corporation Information
6.3.2 Debiotech Description and Business Overview
6.3.3 Debiotech Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Debiotech Microneedle Flu Vaccine Product Portfolio
6.3.5 Debiotech Recent Developments/Updates
6.4 NanoPass Technologies
6.4.1 NanoPass Technologies Corporation Information
6.4.2 NanoPass Technologies Description and Business Overview
6.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 NanoPass Technologies Microneedle Flu Vaccine Product Portfolio
6.4.5 NanoPass Technologies Recent Developments/Updates
6.5 Corium International
6.5.1 Corium International Corporation Information
6.5.2 Corium International Description and Business Overview
6.5.3 Corium International Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Corium International Microneedle Flu Vaccine Product Portfolio
6.5.5 Corium International Recent Developments/Updates
6.6 Becton Dickinson and Company
6.6.1 Becton Dickinson and Company Corporation Information
6.6.2 Becton Dickinson and Company Description and Business Overview
6.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio
6.6.5 Becton Dickinson and Company Recent Developments/Updates
6.7 FluGen
6.6.1 FluGen Corporation Information
6.6.2 FluGen Description and Business Overview
6.6.3 FluGen Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 FluGen Microneedle Flu Vaccine Product Portfolio
6.7.5 FluGen Recent Developments/Updates
6.8 CosMED Pharmaceuticals
6.8.1 CosMED Pharmaceuticals Corporation Information
6.8.2 CosMED Pharmaceuticals Description and Business Overview
6.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio
6.8.5 CosMED Pharmaceuticals Recent Developments/Updates
6.9 Microdermics and OraSure Technologies
6.9.1 Microdermics and OraSure Technologies Corporation Information
6.9.2 Microdermics and OraSure Technologies Description and Business Overview
6.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio
6.9.5 Microdermics and OraSure Technologies Recent Developments/Updates
7 Microneedle Flu Vaccine Manufacturing Cost Analysis
7.1 Microneedle Flu Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Microneedle Flu Vaccine
7.4 Microneedle Flu Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Microneedle Flu Vaccine Distributors List
8.3 Microneedle Flu Vaccine Customers
9 Microneedle Flu Vaccine Market Dynamics
9.1 Microneedle Flu Vaccine Industry Trends
9.2 Microneedle Flu Vaccine Growth Drivers
9.3 Microneedle Flu Vaccine Market Challenges
9.4 Microneedle Flu Vaccine Market Restraints
10 Global Market Forecast
10.1 Microneedle Flu Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Microneedle Flu Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Microneedle Flu Vaccine by Type (2022-2027)
10.2 Microneedle Flu Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Microneedle Flu Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Microneedle Flu Vaccine by Application (2022-2027)
10.3 Microneedle Flu Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Microneedle Flu Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Microneedle Flu Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Microneedle Flu Vaccine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Microneedle Flu Vaccine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Microneedle Flu Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Microneedle Flu Vaccine Covered in This Study
Table 5. Global Microneedle Flu Vaccine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Microneedle Flu Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Microneedle Flu Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Microneedle Flu Vaccine Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Microneedle Flu Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Microneedle Flu Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Microneedle Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microneedle Flu Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Microneedle Flu Vaccine Sales by Region (2016-2021) & (K Units)
Table 16. Global Microneedle Flu Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Microneedle Flu Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Microneedle Flu Vaccine Sales by Country (2016-2021) & (K Units)
Table 19. North America Microneedle Flu Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Microneedle Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Microneedle Flu Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Microneedle Flu Vaccine Sales by Country (2016-2021) & (K Units)
Table 23. Europe Microneedle Flu Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Microneedle Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Microneedle Flu Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Microneedle Flu Vaccine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Microneedle Flu Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Microneedle Flu Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Microneedle Flu Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Microneedle Flu Vaccine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Microneedle Flu Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Microneedle Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Microneedle Flu Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Microneedle Flu Vaccine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Microneedle Flu Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Microneedle Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Microneedle Flu Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Microneedle Flu Vaccine Sales (K Units) by Type (2016-2021)
Table 39. Global Microneedle Flu Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Microneedle Flu Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Microneedle Flu Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Microneedle Flu Vaccine Price (US$/Unit) by Type (2016-2021)
Table 43. Global Microneedle Flu Vaccine Sales (K Units) by Application (2016-2021)
Table 44. Global Microneedle Flu Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Microneedle Flu Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Microneedle Flu Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Microneedle Flu Vaccine Price (US$/Unit) by Application (2016-2021)
Table 48. Sanofi Corporation Information
Table 49. Sanofi Description and Business Overview
Table 50. Sanofi Microneedle Flu Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Sanofi Microneedle Flu Vaccine Product
Table 52. Sanofi Recent Developments/Updates
Table 53. GC Pharma Corporation Information
Table 54. GC Pharma Description and Business Overview
Table 55. GC Pharma Microneedle Flu Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. GC Pharma Microneedle Flu Vaccine Product
Table 57. GC Pharma Recent Developments/Updates
Table 58. Debiotech Corporation Information
Table 59. Debiotech Description and Business Overview
Table 60. Debiotech Microneedle Flu Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Debiotech Microneedle Flu Vaccine Product
Table 62. Debiotech Recent Developments/Updates
Table 63. NanoPass Technologies Corporation Information
Table 64. NanoPass Technologies Description and Business Overview
Table 65. NanoPass Technologies Microneedle Flu Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. NanoPass Technologies Microneedle Flu Vaccine Product
Table 67. NanoPass Technologies Recent Developments/Updates
Table 68. Corium International Corporation Information
Table 69. Corium International Description and Business Overview
Table 70. Corium International Microneedle Flu Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Corium International Microneedle Flu Vaccine Product
Table 72. Corium International Recent Developments/Updates
Table 73. Becton Dickinson and Company Corporation Information
Table 74. Becton Dickinson and Company Description and Business Overview
Table 75. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Becton Dickinson and Company Microneedle Flu Vaccine Product
Table 77. Becton Dickinson and Company Recent Developments/Updates
Table 78. FluGen Corporation Information
Table 79. FluGen Description and Business Overview
Table 80. FluGen Microneedle Flu Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. FluGen Microneedle Flu Vaccine Product
Table 82. FluGen Recent Developments/Updates
Table 83. CosMED Pharmaceuticals Corporation Information
Table 84. CosMED Pharmaceuticals Description and Business Overview
Table 85. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. CosMED Pharmaceuticals Microneedle Flu Vaccine Product
Table 87. CosMED Pharmaceuticals Recent Developments/Updates
Table 88. Microdermics and OraSure Technologies Corporation Information
Table 89. Microdermics and OraSure Technologies Description and Business Overview
Table 90. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product
Table 92. Microdermics and OraSure Technologies Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Microneedle Flu Vaccine Distributors List
Table 96. Microneedle Flu Vaccine Customers List
Table 97. Microneedle Flu Vaccine Market Trends
Table 98. Microneedle Flu Vaccine Growth Drivers
Table 99. Microneedle Flu Vaccine Market Challenges
Table 100. Microneedle Flu Vaccine Market Restraints
Table 101. Global Microneedle Flu Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 102. Global Microneedle Flu Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 103. Global Microneedle Flu Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 104. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 105. Global Microneedle Flu Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 106. Global Microneedle Flu Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 107. Global Microneedle Flu Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 108. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 109. Global Microneedle Flu Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 110. Global Microneedle Flu Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 111. Global Microneedle Flu Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 112. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Microneedle Flu Vaccine
Figure 2. Global Microneedle Flu Vaccine Market Share by Type in 2020 & 2027
Figure 3. Solid Microneedle Product Picture
Figure 4. Hollow Microneedle Product Picture
Figure 5. Coated Microneedle Product Picture
Figure 6. Dissolving Microneedle Product Picture
Figure 7. Global Microneedle Flu Vaccine Market Share by Application in 2020 & 2027
Figure 8. Influenza A
Figure 9. Influenza B
Figure 10. Global Microneedle Flu Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Microneedle Flu Vaccine Market Size 2016-2027 (US$ Million)
Figure 12. Global Microneedle Flu Vaccine Sales 2016-2027 (K Units)
Figure 13. Global Microneedle Flu Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Microneedle Flu Vaccine Sales Share by Manufacturers in 2020
Figure 15. Global Microneedle Flu Vaccine Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Microneedle Flu Vaccine Players: Market Share by Revenue in 2020
Figure 17. Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Microneedle Flu Vaccine Sales Market Share by Region (2016-2021)
Figure 19. Global Microneedle Flu Vaccine Sales Market Share by Region in 2020
Figure 20. Global Microneedle Flu Vaccine Revenue Market Share by Region (2016-2021)
Figure 21. Global Microneedle Flu Vaccine Revenue Market Share by Region in 2020
Figure 22. U.S. Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Microneedle Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Microneedle Flu Vaccine by Type (2016-2021)
Figure 47. Sales Market Share of Microneedle Flu Vaccine by Application (2016-2021)
Figure 48. Sales Market Share of Microneedle Flu Vaccine by Application in 2020
Figure 49. Revenue Share of Microneedle Flu Vaccine by Application (2016-2021)
Figure 50. Revenue Share of Microneedle Flu Vaccine by Application in 2020
Figure 51. Manufacturing Cost Structure of Microneedle Flu Vaccine
Figure 52. Manufacturing Process Analysis of Microneedle Flu Vaccine
Figure 53. Microneedle Flu Vaccine Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs